Watson Pharmaceuticals to buy private generic drug maker Arrow Group for $1.75B in cash, stock

NEW YORK — Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock.

Poll

Do you think Barack Obama is a good choice for Nobel Peace Prize

View Results

Comments

Show all Polls
Loading ... Loading ...
Protected by Comment Guard Pro